Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.8%

2 terminated out of 53 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (19)
P 1 (3)
P 3 (2)

Trial Status

Recruiting19
Completed14
Unknown11
Active Not Recruiting3
Withdrawn2
Terminated2

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07206355Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT05692596Active Not Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

NCT03085004Phase 3TerminatedPrimary

CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

NCT02775461Recruiting

Pancreas Registry and High Risk Registry

NCT05873699Phase 1RecruitingPrimary

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

NCT04275557Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

NCT03334708Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

NCT06305728RecruitingPrimary

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

NCT04291651RecruitingPrimary

UCSF PANC Cyst Registry

NCT07173257Recruiting

PROMs After Pancreatectomy

NCT06939023Not ApplicableRecruiting

Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)

NCT03492151RecruitingPrimary

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

NCT07136324Active Not RecruitingPrimary

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

NCT05334836Not ApplicableRecruiting

Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features

NCT06320990Phase 1RecruitingPrimary

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

NCT06564571Recruiting

Artificial Intelligence in Endoscopic Ultrasound

NCT03260842RecruitingPrimary

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

NCT06867172Recruiting

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

NCT06276764Enrolling By Invitation

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

NCT02422147CompletedPrimary

EUS-guided Ablation of Pancreatic Cyst Neoplasms

Scroll to load more

Research Network

Activity Timeline